Opinion
Video
Author(s):
A collection of clinical insights on prurigo nodularis, exploring awareness and educational efforts as well as trends in treatment.
This is a modal window.
Video content above is prompted by the following:
There are two 2 systemic biologic treatments that have been recently approved for prurigo nodularis within the past few years. Can you describe these two 2 agents, including mechanisms of action, efficacy and safety, and what differentiates them from each other and from other PN treatment options?
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.